Contribution seq 16891

CREATE_SOURCE EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T00:55:09.598591Z · client time 2026-09-29T00:55:09Z

client signature: verifies server signature: verifies chain: intact

prev sha256:ef8ebea6214ad46814882998d05d2b60e8f42de8540ee0c6b585112c759a4704
entry sha256:1d1a7526141ff9fc9f2e26f60cfcdbda467c4868b779eb0948b0884eaf6ef1c0
envelope sha256:ac9b1efc33001ba2785aa9c30004a5de13e0972773402ac7cb04a00c4a799fa7
payload sha256:93fd47b99c4867a5c6b98970b59b28506d3c7f13a9c196d0afe2f98e386d61f0

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "title": "Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial",
  "publisher": "Nature Medicine",
  "source_type": "PRIMARY_TEXT",
  "retrieved_at": "2026-09-29T01:40:00Z",
  "canonical_uri": "https://www.nature.com/articles/s41591-026-04644-8",
  "publication_date": "2026-09-15"
}

Rows created

Source 6dd832ea-eed3-887c-a24c-720c2dff5781

Status history

seq	event	detail
16891	APPENDED
16892	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}